ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Epilepsy & Behavior
Volume 13, Issue 1, July 2008, Pages 102-108
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (130 K)

Article Toolbox
  E-mail Article   
  Add to my Quick Links   
Bookmark and share in 2collab (opens in new window)
Request permission to reuse this article
  Cited By in Scopus (0)
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.yebeh.2008.02.009    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2008 Elsevier Inc. All rights reserved.

Acceptance and Commitment Therapy and yoga for drug-refractory epilepsy: A randomized controlled trial

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Tobias Lundgrena, Corresponding Author Contact Information, E-mail The Corresponding Author, JoAnne Dahla, Nandan Yardib and Lennart Melina

aDepartment of Psychology, University of Uppsala, Uppsala, Sweden

bYardi Hospital, Pune, India


Received 4 January 2008; 
revised 7 February 2008; 
accepted 10 February 2008. 
Available online 14 March 2008.

Abstract

Objective

There is a need for controlled outcome studies on behavioral treatment of epilepsy. The purpose of this study was to evaluate Acceptance and Commitment Therapy (ACT) and yoga in the treatment of epilepsy.

Methods

The design consisted of a randomized controlled trial with repeated measures (N = 18). All participants had an EEG-verified epilepsy diagnosis with drug-refractory seizures. Participants were randomized into one of two groups: ACT or yoga. Therapeutic effects were measured using seizure index (frequency × duration) and quality of life (Satisfaction with Life Scale, WHOQOL-BREF). The treatment protocols consisted of 12 hours of professional therapy distributed in two individual sessions, two group sessions during a 5-week period, and booster sessions at 6 and 12 months posttreatment. Seizure index was continuously assessed during the 3-month baseline and 12-month follow-up. Quality of life was measured after treatment and at the 6-month and 1-year follow-ups.

Results

The results indicate that both ACT and yoga significantly reduce seizure index and increase quality of life over time. ACT reduced seizure index significantly more as compared with yoga. Participants in both the ACT and yoga groups improved their quality of life significantly as measured by one of two quality-of-life instruments. The ACT group increased their quality of life significantly as compared with the yoga group as measured by the WHOQOL-BREF, and the yoga group increased their quality of life significantly as compared with the ACT group as measured by the SWLS.

Conclusions

The results of this study suggest that complementary treatments, such as ACT and yoga, decrease seizure index and increase quality of life.

Keywords: Epilepsy; Acceptance and Commitment Therapy; Yoga; India

Article Outline

1. Introduction
2. Methods
2.1. Design
2.2. Subjects
2.3. Procedure
2.4. Independent variable
2.4.1. Acceptance and commitment therapy
2.4.1.1. Session 1: Individual session
2.4.1.2. Session 2: Group session (six to eight participants)
2.4.2. Yoga
2.5. Dependent variables
2.6. Statistical analyses
2.7. Ethical considerations
3. Results
3.1. Seizure frequency
3.2. Seizure index
3.3. Quality of life
4. Discussion
References

Corresponding Author Contact InformationCorresponding author. Address: Department of Psychology, Uppsala University, Trädgårdsgatan 20, Box 1225, 751 42 Uppsala, Sweden. Fax: +46 18 471 21 23.

Epilepsy & Behavior
Volume 13, Issue 1, July 2008, Pages 102-108
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.